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High glucose levels inhibit focal adhesion kinase-mediated It is important to maintain adequate peritoneal func-
wound healing of rat peritoneal mesothelial cells. tion for long-term continuous ambulatory peritoneal di-
Background. The peritoneum is progressively denuded of alysis (CAPD) therapy. Loss of ultrafiltration is one of
its mesothelial cell monolayer in patients on continuous ambu- the most important reasons for discontinuation of CAPDlatory peritoneal dialysis (CAPD). These alterations of the
[1, 2]. Furthermore, some patients develop sclerosingmesothelium cause membrane dysfunction and progressive
encapsulating peritonitis, a condition that hinders CAPDperitoneal fibrosis. Integrins regulate cell motility and play an
important role in wound healing. We investigated the effects of and is associated with high mortality [3–5]. The perito-
high glucose on the regeneration process of the peritoneal neal membrane and the monolayer of mesothelial cells
mesothelial cell monolayer using cultured rat peritoneal meso- are the key structures involved in regulating permeability
thelial cells (RPMC). and ultrafiltration as well as biological and physical barri-
Methods. The effects of glucose or mannitol on the regenera-
ers in patients with CAPD. Morphological studies of thetion of RPMC and formation of focal adhesions were examined
peritoneal membrane in patients chronically exposed toby in vitro wound healing assay and immunocytochemistry, re-
the dialysis fluid have shown loss of mesothelial cellsspectively. Activities of focal adhesion kinase (FAK) and its
downstream p130Cas were examined by Western blotting. Ef- and replacement of the membrane by collagen-based
fects of wild-type and dominant-negative FAK on RPMC mi- fibrous tissue [1, 6]. Furthermore, shedding and regener-
gration were examined by a transient transfection assay. ation of peritoneal mesothelial cells continuously occur
Results. Cell migration over fibronectin (FN) was clearly
during CAPD in response to direct exposure of mesothe-inhibited in culture media containing high glucose (28 to 140
lial membrane to non-physiological dialysis solutionmmol/L). RPMC formed focal adhesions on FN in the presence
soon after initiation of CAPD [7, 8]. Peritonitis acceler-of a regular glucose concentration (5.6 mmol/L); however, tyro-
sine phosphorylation of FAK and p130Cas and formation of ates such damage of the peritoneal membrane, which is
focal adhesions observed by FAK and vinculin staining were followed by shedding of mesothelial cells and peritoneal
substantially inhibited by high glucose. Mannitol also induced fibrosis. These changes in mesothelial cells are associated
significant inhibitory effects, but these were milder than those
with high permeability of solutes and loss of ultrafiltra-of glucose. Transfection of dominant-negative FAK inhibited
tion [1, 4, 9]. Therefore, there is a pressing need for acell migration in a regular glucose concentration, whereas over-
peritoneal dialysate that is less harmful to the peritonealexpression of wild-type FAK abrogated glucose-induced inhibi-
tion of cell migration. membrane and that does not inhibit regeneration of the
Conclusions. Our results demonstrate that high glucose con- mesothelial cell monolayer.
centrations as well as high osmolarity inhibit FAK-mediated mi- The peritoneal dialysate, containing non-physiological
gration of mesothelial cells, and suggest that dialysates contain-
materials such as glucose, hypertonic, lactate-buffered,ing high glucose concentrations may cause peritoneal damage
and acidic solution, is thought to be toxic and is impli-by inhibiting wound healing of the mesothelial cell monolayer.
cated in long-term damage of the peritoneal membrane
[6, 10]. In particular, there is a growing body of evidence
indicating that high glucose concentration plays impor-Key words: continuous ambulatory peritoneal dialysis, dialysate, focal
adhesion kinase, peritoneal mesothelial cells, integrins, glucose. tant roles in the progression of mesothelial fibrosis in
patients with CAPD. Clinically, peritoneal sclerosis andReceived for publication March 14, 2002
increased membrane solute transport are associated withand in revised form August 28, 2002
Accepted for publication September 24, 2002 the use of hypertonic glucose dialysate [11]. These find-
ings suggest that high glucose concentrations in perito- 2003 by the International Society of Nephrology
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neal dialysis solution may induce accumulation of ECM taining 0.25% trypsin and 1 mmol/L EDTA was placed
on the peritoneum for 15 minutes. The recovered fluidand eventual peritoneal fibrosis. On the other hand,
there is limited information about the effect of high glu- was centrifuged at 1000 rpm for five minutes after adding
Dulbecco’s modified Eagle’s medium (DMEM) con-cose concentration on the regeneration of mesothelial
monolayer. Growth factors, such as platelet-derived growth taining 10% fetal bovine serum (FBS). Cells were cul-
tured in DMEM supplemented with 10% FBS. Cellsfactor (PDGF), fibroblast growth factor (FGF), trans-
forming growth factor- (TGF-), and epidermal growth were identified as RPMC by its cobblestone appearance
(Fig. 3) and positive staining for monoclonal anti-humanfactor (EGF) are known to induce chemotaxis of various
cells [12–15]. However, to our knowledge there are no mesothelial cell antibody (HBME-1; DAKO, Carpin-
teria, CA, USA), monoclonal anti-cytokeratin 19 anti-studies that have examined the effects of high glucose
concentration per se on integrin-mediated cell migration body (RPN 1165; Amersham Life Science, Little Chal-
font, UK), and monoclonal anti-cytokeratin 18 antibodyor formation of focal adhesions.
Integrins are major adhesion receptors composed of (#10500, Cappel; ICN Biomedicals, Aurora, OH, USA)
by immunocytochemistry using Cy-3-conjugated goatpairs of  and  transmembrane subunits that mediate
the specific association of cells with the extracellular antibody to mouse IgG as a secondary antibody (Jack-
son Immunoresearch Laboratories, West Grove, PA,matrix (ECM) and an assembly of cytoplasmic cytoskele-
tal and signaling complexes, including focal adhesion USA). RPMC were maintained in DMEM containing
5.6 mmol/L glucose, 10% FBS, 100 U/mL penicillin, andkinase (FAK), p130Cas, paxillin, vinculin, tensin, and lo-
calized phosphotyrosine, which lead to activation of vari- 100g/mL streptomycin in 5% CO2 at 37C. RPMC were
used between passages 3 and 6.ous intracellular signal transduction pathways [16–18].
Of particular interest is FAK, which is a key molecule
Materialsin integrin-mediated regulation of cell spreading and mi-
gration. FAK expression is enhanced in rapidly migrating Monoclonal antibodies for paxillin, tensin, FAK, p130Cas,
and phosphotyrosine (PY20) were obtained from Trans-keratinocytes [19] and in invasive human tumors [20],
and migration of endothelial cells is also positively asso- duction Laboratories (Lexington, KY, USA). Mono-
clonal antibodies against vinculin (VIN-11-5) and HAciated with FAK activity [21]. Cells from FAK-deficient
mice [22] and cells in which FAK signaling is inhibited (12CA5) were from Sigma Aldrich (St. Louis, MO, USA)
and Boehringer Mannheim (Indianapolis, IN, USA), re-by dominant-negative FAK [23] or specific phosphatase
exhibit reduced cell migration [15, 24–27], whereas over- spectively. Rabbit polyclonal antibodies against Y397-
phosphorylated FAK were from BioSource Interna-expression of FAK increases migration toward FN [28].
However, involvement of integrin in peritoneal dialysis tional (Camarillo, CA, USA). d-glucose and d-mannitol
were purchased from Nacalai (Tokyo, Japan) and usedhas not been thoroughly investigated. In particular, in-
tegrin-mediated signaling in peritoneal mesothelial cells for cell culture immediately after a 0.2 m filter steriliza-
tion to avoid the effects of glucose degradation productsis poorly understood. Various phenotypes of integrin sub-
units, such as 3 and 1, 2, 3, 5, and v are constitutively ex- (GDP). Human fibronectin (FN) was from Sigma. Cy-
3-conjugated goat antibody to mouse IgG was from Jack-pressed in human peritoneal mesothelial cells (HPMC)
[29]. Heparin-binding epidermal growth factor-like growth son Immunoresearch Laboratories.
factor (HB-EGF) stimulates 1 integrin expression and
Immunoprecipitation and Western blottingpromotes HPMC migration [30]. The present study was
designed to investigate the effects of high glucose con- After incubating cells in 10% serum-containing DMEM
supplemented with indicated amounts of either glucosecentration as well as high osmolarity on wound healing
of injured mesothelial cell monolayer in vitro, especially or mannitol for 24 hours on 10 g/mL FN-coated Petri
dishes, cells were solubilized in RIPA buffer [50 mmol/Lfocusing on integrin-mediated cell adhesion mechanisms.
Our studies analyzed the underlying mechanisms of dial- Tris, pH 7.4, 150 mmol/L NaCl, 1% Nonidet P-40, 0.25%
sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS),ysate-induced peritoneal injury.
1 mmol/L egtazic acid (EGTA), 1 mmol/L phenylmethyl-
sulfonyl fluoride (PMSF), 1 mmol/L sodium orthovana-
METHODS
date, 1 mmol/L sodium fluoride, and a protease inhibitor
Cell culture mixture (Boehringer Mannheim, Mannheim, Germany)].
Homogenates were clarified by centrifugation at 15,000Rat peritoneal mesothelial cells (RPMC) were ob-
tained using a standard trypsin/ethylenediaminetetraace- g for 15 minutes at 4C. Immunoprecipitation was per-
formed using anti-p130Cas (4 g/mL) antibody as describedtic acid (EDTA) digestion method from the peritoneal
wall of male Wistar rats weighing about 150 g [31]. Briefly, previously [24]. Immunoprecipitates were resolved by
SDS-polyacrylamide gel electrophoresis (SDS-PAGE),the excised peritoneal flap was stretched on a sterile
culture plate, and phosphate-buffered saline (PBS) con- and analyzed by Western blotting with RC20 (1:2500)
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or p130Cas (1:1000) antibodies using the enhanced chemi- PCR (Stratagene, La Jolla, CA, USA) and confirmed
by DNA sequencing [33]. Puromycin-resistant plasmidluminescence system (ECL; Amersham Life Science, Ar-
lington Heights, IL, USA) [32]. Phosphorylation of FAK pHA262pur was obtained from Dr. Heinte Riele (Di-
vision of Molecular Carcinogenesis, The Netherlands Can-was analyzed by Western blotting using anti-phospho-
FAK monoclonal antibody (1:2000) as described pre- cer Institute, Netherlands). Either wild-type or Y397F HA-
FAK (5 g) was transfected into preconfluent RPMCviously [33].
plated on 10 g/mL FN-coated 8-well chamber slides
Cell migration and spreading assays (Nalge Nunc International, Naperville, IL, USA) using
the cationic liposome (lipofectamine; Gibco BRL, Gai-Cell migration was measured using an in vitro wound
healing assay as described previously [24, 25]. Briefly, in thersburg, MD, USA)-mediated transfection method
[35, 36]. To increase the expression of transfected genes,vitro “scratch” wounds were created by scraping conflu-
ent cell monolayers plated on 10 g/mL FN-coated Petri 5 mmol/L sodium butyrate was added to the culture
medium for 24 hours [24]. At 24 hours after transfection,dishes with a sterile pipette tip. Numbers of migrating cells
from the wound edge were quantified after 24-hours of cells were used for in vitro wound healing assay as de-
scribed above. Cells expressing HA-FAK were con-incubation. Each determination represents the mean value
( SD) of eight individual experiments. Cells spreading firmed by immunocytochemistry using anti-HA mono-
clonal antibody.on 10 g/mL FN-coated glass cover slips were quantified
as described previously [24] by scoring at least 100 cells
Statistical analysisper sample and pooling data of five experiments.
Data are expressed as mean  SD. Differences be-
Immunocytochemistry tween groups were examined for statistical significance
using one-way analysis of variance (ANOVA) or theImmunocytochemistry was performed as described
[24]. RPMC were plated on glass cover slips coated with Student t test. A P value less than 0.05 denoted the
presence of a statistically significant difference.FN (10 g/mL). Cells were allowed to spread for the in-
dicated times in DMEM containing 1% bovine serum
albumin (BSA), fixed with 4% paraformaldehyde and
RESULTS
0.5% Triton X-100 in PBS for five minutes, and then
Effects of high glucose concentration on cell viabilityincubated with 4% paraformaldehyde in PBS for another
20 minutes. Cytoskeletal proteins were visualized by in- First, the effects of high glucose on viability of RPMC
were examined, since high glucose is known to inducecubating first with monoclonal antibodies to paxillin
(0.5 g/mL), tensin (5 g/mL), FAK (5 g/mL), phos- apoptosis and growth inhibition [37], which might influ-
ence the results of the cell migration assay. The effectphotyrosine (10 g/mL), or vinculin (20 g/mL), and
then with Cy-3-conjugated goat antibody to mouse IgG of glucose on cell cycle of RPMC was examined in 0.5
or 10% FBS. By FACS analysis, in culture medium with(dilution 1/600) and assessed by using confocal micros-
copy (LSM410, Carl Zeiss, Oberkochen, Germany). regular glucose concentration (5.6 mmol/L) supple-
mented with 10% serum, there was a decrease in sub-
Cell cycle analysis G1 population and an increase in G2/M population com-
pared with those of serum-starved regular glucose me-Fluorescence-activated cell sorter (FACS) analysis
was carried out with 1  105 cells plated on 6-cm plastic dium after 24 hours of incubation (Fig. 1A). Higher con-
centrations of glucose resulted in a decrease in G2/Mtissue culture dishes in 10% serum-containing medium
[33, 34]. After 24 hours of exposure to DMEM containing population and an increase in sub-G1 population. These
changes were statistically significant at 222 mmol/L glu-indicated concentration of glucose, cells were collected,
washed with PBS, and fixed in 70% ethanol for two cose, indicating that high glucose concentration in the
culture medium increases growth-arrested cells and in-hours at 4C, and washed once with PBS. After treatment
of cells with 10 g/mL ribonuclease (Wako, Osaka, hibits cell cycle progression. Furthermore, the increase in
lactate dehydrogenase (LDH) released into the cultureJapan) for 15 minutes at 37C, fixed cells were stained
with 50 g/mL propidium iodide (Sigma Aldrich) for 15 medium by RPMC was similar in media containing 222
mmol/L glucose or mannitol (Fig. 1B). Thus, 222 mmol/Lminutes. DNA content was subsequently measured by
FACScan (Becton Dickinson, San Jose, CA, USA). glucose and mannitol exhibited significant cytotoxicity,
and for this reason we selected glucose or mannitol at
Plasmids and transfection assay concentrations less than 140 mmol/L in subsequent ex-
periments to assess cell migration. Interestingly, acidicHemagglutinin (HA)-tagged FAK was kindly pro-
vided by Kenneth M. Yamada (NIDCR, NIH, Bethesda, culture medium had no significant effects on the cell
cycle (Fig. 1A). We also examined the effects of 140MD, USA) [24]. The point mutant Y397F was intro-
duced into HA-FAK by site-directed mutagenesis using mmol/L glucose, 140 mmol/L mannitol, and acidosis (pH
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Fig. 2. Dose response of glucose-induced inhibition of mesothelial cell
migration. In vitro “scratch” wounds were created by scraping confluent
monolayers of cultured rat peritoneal mesothelial cells in FN-coated
dishes. After 24 hours of incubation in 10% serum-containing DMEM
supplemented with the indicated glucose concentration, cell numbers
migrating into the wounded area from the wound edge were counted.
The values are expressed as migrating cell number per 1 mm wound
width. Data are mean  SD values of four independent experiments.
6.0) on cell growth to further rule out the effect of cell
growth on cell migration. After 24 hours of incubation,
there was a slight but not significant decrease in cell
number in all culture media (Fig. 1C).
Effects of high glucose concentration on cell migration
Next, RPMC migration was examined using the in vitro
wound healing assay by creating scratch wounds in con-
fluent monolayers of RPMC. After a 24-hour incubation
in 10% serum-containing DMEM supplemented with the
indicated glucose concentrations, the number of cells
migrating from the wound edge decreased in a glucose
concentration-dependent manner (Fig. 2). At 140 mmol/L,
respectively. The cell cycle was analyzed by FACScan after a 24 hour
incubation in each medium as described in the Methods section. The
numbers in each panel represent the percentage of cells exhibiting mean
channel fluorescence (FL2-H) below the G1 phase or in the G2/M phase
of the cell. Symbols are: () cells below the G1 phase; () cells in
the G2/M phase. Data are mean  SD values of four independent
experiments. *P 0.05 vs. control with 10% FBS. (B) Effects of glucose
() and mannitol () on LDH release in RPMC. RPMC were incubated
for 24 hours in 10% FBS-containing culture medium supplemented
with indicated amount of either glucose or mannitol. Results are relative
LDH activity in culture supernatant versus total cellular LDH activity.
Values are adjusted to the control (100). Data are mean  SD values
of five independent experiments (*P  0.01 vs. control). (C ) Effects
of glucose, mannitol, and acidosis on cell growth. RPMC were incubated
Fig. 1. Effects of glucose, mannitol, and acidosis on viability of rat per- for 24 hours in 10% FBS-containing regular culture medium, culture
itoneal mesothelial cells (RPMC). (A) FACS analysis. Cultured RPMC medium supplemented with either 140 mmol/L glucose or mannitol, or
were incubated with or without indicated amount of glucose or acidic acidic culture medium (pH 6.0) with regular glucose concentration. Cell
culture medium for 24 hours. Control culture medium contained regular numbers were counted before the incubation (baseline) and 24 hours
glucose concentration (5.6 mmol/L). Glucose concentrations, 28, 75.6, after exposure and expressed as ratios against the value of baseline
140, and 222 mmol/L, correspond to 0.5%, 1.35%, 2.5%, and 4% glucose, (100). Data are mean  SD values of six independent experiments.
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Fig. 3. Effects of various dialysate ingredients on cell migration. In vitro wound healing assay was performed as described in the legend to Figure
2 in 10% serum-containing DMEM supplemented with either regular glucose concentration, indicated concentration of glucose or mannitol, or
acidic medium with regular glucose concentration. After 24-hours of incubation, cells migrating from the wound edge were photographed (A )
and counted (B ). Dotted lines in panel A indicate the wound edge. Data are mean  SD values of five independent experiments (*P  0.05 vs.
75.6 mmol/L glucose).
glucose reduced cell migration by 76.6% (23.4% of con- and localized phosphotyrosine-containing focal adhe-
sions and actin microfilament (stress fiber) as determinedtrol, P  0.001). Figure 3A shows representative photo-
graphs of cells migrating into the wound. Both 140 by staining with rhodamine-labeled phalloidin (data not
shown).mmol/L glucose and mannitol showed substantial inhibi-
tion of cell migration on FN, and cell migration was re-
Effects of high glucose concentration on cell spreadingduced in glucose and mannitol concentration-dependent
manner. However, the effect of 75.6 mmol/L mannitol on To further assess glucose inhibition of focal adhesions,
cell spreading onto FN was examined. Both glucose andcell migration was less than that of 75.6 mmol/L glucose
(glucose; 40.3% of control, mannitol; 69.9% of control, mannitol showed marked reduction of cell spreading on
FN at 0.5 to four hours (Fig. 6). In a two hour assay,P  0.05, Fig. 3B). On the other hand, there was no sig-
nificant inhibition of RPMC migration under acidic con- only 21.7  3.5% of cells in 75.6 mmol/L glucose had
spread, whereas 59.0  3.6% of cells in regular cultureditions compared with cells grown at normal pH.
medium had spread (P 0.001). Mannitol (75.6 mmol/L)
Effects of high glucose concentration on focal also reduced cell spreading (35.0  7.2%) but was less
adhesion formation effective compared to 75.6 mmol/L glucose (P  0.05;
To explore the mechanism underlying the effect of Fig. 6). An acidic condition (pH 6.0) had no effect on
high glucose on RPMC migration, we next examined the cell spreading, while excessive acidosis (pH 5.0) showed
effect of high glucose on focal adhesion formation. After slight but significant reduction in cell spreading at one
two hours of adhesion to FN, RPMC formed numerous to four hours (Fig. 6).
focal adhesions, which contained tensin, paxillin, vinculin,
Inhibition of FAK and p130Cas by highFAK, and localized phosphotyrosine, as observed in many
glucose concentrationother cells (Fig. 4). In cells incubated with 140 mmol/L
glucose, the total number of focal adhesions stained by Cell interactions with extracellular matrix proteins
through integrin receptors can mediate transmembraneanti-vinculin and FAK antibodies was substantially re-
duced in comparison with the control after one hour of signal transduction, including integrin-mediated tyrosine
phosphorylation of FAK and p130Cas [24, 25]. High con-spreading onto FN-coated cover slips (Fig. 5). Similarly,
mannitol inhibited focal adhesion formation. High glu- centrations of glucose and mannitol suppressed tyrosine
phosphorylation of FAK after adhesion to FN, whereascose also down-regulated formation of tensin-, paxillin-,
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Fig. 4. Formation of focal adhesions in cul-
tured peritoneal mesothelial cells. Cultured
peritoneal mesothelial cells were allowed to
spread on cover slips coated with FN (10
g/mL) for two hours and were then immuno-
stained with antibodies to tensin, phosphoty-
rosine, paxillin, vinculin, or FAK. Arrowheads
indicate representative focal adhesions (scale
bar, 50 m).
Fig. 5. Inhibition of focal adhesion formation by glucose and mannitol. Cultured peritoneal mesothelial cells were immunostained with antibody
to vinculin (upper panels) or FAK (lower panels) one hour after plating on FN (10 g/mL)-coated cover slips. Arrows and arrowheads are samples
of cells spread and cells not spread, respectively (scale bar, 50 m).
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Fig. 6. Inhibition of cell spreading by glucose and mannitol. Cultured peritoneal mesothelial cells were allowed to spread on cover slips coated
with FN (FN, 10 g/mL) for indicated time, fixed with 4% paraformaldehyde, and immunostained with anti-vinculin antibody. The percentage of
cells spread on FN was determined. Data are mean  SD values of five independent experiments.
an acidic condition (pH 6.0) had no effects on phosphory-
lation of these molecules (Fig. 7A). The adapter protein
p130Cas is a downstream effector of FAK, and it is charac-
teristically tyrosine phosphorylated after increases in
FAK and c-Src kinase activity in response to attachment
to the extracellular matrix [38]. Therefore, we investi-
gated whether p130Cas also is implicated in high glucose-
induced inhibition of cell migration as a downstream
event of FAK dephosphorylation. Again, tyrosine phos-
phorylation level of p130Cas was repressed by both high
glucose and mannitol concentrations (Fig. 7B), sug-
gesting that high osmolarity also inhibits integrin-medi-
ated intracellular signaling.
Effects of wild-type and dominant-negative FAK on
glucose inhibition of mesothelial cell migration
The correlation of FAK dephosphorylation with inhi-
bition of cell migration suggests that the inhibition of
migration may be a downstream event of FAK dephos-
phorylation by glucose. Next, we tested whether the domi-
nant-negative form of FAK could inhibit cell migration,
and whether FAK overexpression, in turn, could attenu-
ate the effects of high glucose on cell migration. Cells
were transfected either wild-type or Y397F HA-FAK.
After 24 hours of transfection, cells expressing either
Fig. 7. Inhibition of FAK and p130Cas phosphorylation by glucose andwild-type or Y397F HA-FAK were incubated with cul-
mannitol. Total cell lysates were prepared from cultured peritoneal
ture medium with regular glucose concentration or 140 mesothelial cells in suspension or cells spread on FN for 24 hours, and
were immunoblotted using either anti-phospho-FAK (A, upper panel)mmol/L glucose for another 24 hours. Transfected cells
or total FAK antibodies (A, lower panel). In B, lysates from eachwere identified by positive staining for HA. We exam-
mesothelial cells were immunoprecipitated with anti-p130Cas antibody
ined the effects of wild-type or Y397F HA-FAK on cell (IP: p130Cas) and immunoblotted with anti-phosphotyrosine (B, upper
panel) or anti-p130Cas antibodies (B, lower panel).number to rule out possible effects of these constructs
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Fig. 8. Effects of wild-type and dominant-negative FAK on glucose inhibition of mesothelial cell migration. Mesothelial cells were transfected
without or with either wild-type or Y397F FAK and used for in vitro migration assay after 24 hours. In vitro “scratch” wounds were created by scraping
confluent cell monolayers into 10 g/mL FN-coated dishes. After 24 hours, cells expressing HA-FAK were identified by immunocytochemistry using
anti-HA antibody. Cell numbers (A), cell spreading (B), and numbers of cells migrating from the wound edge (C ) were counted. The transfection
efficiencies for wild-type and Y397F FAK were 13  7% and 15  5%, respectively; control  5.6 mmol/L glucose and glucose  140 mmol/L
glucose, while baseline represents the cell numbers counted before the incubation. Data are mean  SD values of five independent experiments
(*P  0.001 vs. control cells without FAK transfection in regular glucose concentration, **P  0.01 vs. cells without FAK transfection in 140
mmol/L glucose).
on cell growth that may affect the results of cell migra- phorylation. These data support our model in which high
tion. Both wild-type and Y397F FAK showed a minimal glucose levels affect cell spreading through interference
effect on cell number during the experiment (Fig. 8A). with FAK signaling.
As shown in Figure 8 B and C, although overexpression of
wild-type FAK had minimal to only very slightly positive
DISCUSSIONeffects on cell spreading and migration on FN, expression
The major findings of the present study were: (1) glu-of Y397F-FAK, which results in inhibition of phosphory-
cose inhibited mesothelial cell migration and spreadinglation of endogenous FAK [33], clearly reduced cell
in a dose-dependent manner (Fig. 2). (2) These alter-spreading and migration even in the presence of regular
ations were associated with inhibition of focal adhesionglucose concentration. Furthermore, overexpression of
formation and phosphorylation of FAK and its down-wild-type FAK abrogated high glucose-induced down-
stream p130Cas (Figs. 4 to 7). (3) The dominant-negativeregulation of cell spreading (101.2% of control) and mi-
form of FAK inhibited cell migration even in regulargration (86.6% of control), suggesting that FAK is an
glucose medium as effectively as in high glucose mediumimportant mediator of high glucose-induced inhibition
(Fig. 8). (4) Overexpression of wild-type FAK reversedof cell migration.
the inhibitory action of high glucose on cell migrationWe also confirmed the effect of overexpression of
(Fig. 8). To our knowledge, our studies provide the firstwild-type or Y397F FAK on FAK phosphorylation levels
evidence that high glucose can restrain the capacity ofas described previously [27]. RPMC were cotransfected
peritoneal mesothelial cells to migrate over one of thewith either wild-type or Y397F FAK and a puromycin-
basement membrane matrix component. These resultsresistant plasmid, pHA262pur, and selected using puro-
suggest that high glucose concentrations in peritonealmycin. This selection for transient transfectants resulted
dialysates might suppress peritoneal cell regeneration byin90% positive cells expressing HA, as determined by
inhibiting integrin-mediated cell migration, which resultsfluorescence microscopy. Transfection of Y397F FAK
in a loss of the mesothelial cell monolayer, as seen inresulted in decrease in FAK phosphorylation levels (12
many patients undergoing long-term CAPD therapy.4% of non-transfected cells) even in regular glucose con-
Our results also showed that mannitol had similar,centration. Furthermore, overexpression of wild-type FAK
though lesser inhibitory effects on cell migration andrescued high glucose-induced decrease in FAK phos-
spreading compared to those of glucose at equivalent os-phorylation levels (101  13% of non-transfected cells
molarity, suggesting that not only high glucose concen-in regular glucose concentration). Thus, we confirmed
tration but also hyperosmolarity per se might play a rolethat overexpression of wild-type or dominant-negative
FAK indeed led to higher or lower levels of FAK phos- in these inhibitory effects. Because it has been reported
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that high glucose and hyperosmolarity inhibit cell prolif- phosphorylation levels, are consistent with these reports,
and suggest that FAK plays an important role in celleration and induce apoptosis after long-term exposure
migration even in peritoneal mesothelial cells. That glu-[37, 39, 40], these inhibitory effects of glucose and manni-
cose inhibition of cell migration could be reversed bytol on cell migration might stem from reduced cell viabil-
intracellular overexpression of wild-type FAK furtherity. Therefore, we examined the effects of glucose and
confirms the importance of FAK in glucose-induced inhi-mannitol on cell cycle, LDH release, and cell growth less
bition of cell migration.than 24 hours after exposure to exclude any influence
p130Cas has been reported to be a mediator of FAK-of cell viability on cell migration. No significant changes
promoted cell migration in several cell lines [43]. In thewere observed in cell viability compared to regular me-
present study, we showed that phosphorylation of p130Casdium up to 140 mmol/L at 24 hours, whereas 222 mmol/L
is also inhibited, similar to FAK, by high glucose and man-glucose and mannitol induced significant cytotoxicity.
nitol. p130Cas is a signal transduction protein that bindsTherefore, glucose and mannitol concentrations below
directly to FAK and is phosphorylated upon cell adhe-140 mmol/L were used for evaluating cell migration and
sion to extracellular matrix proteins in a FAK- and Src-spreading. Under these conditions, we observed signifi-
dependent manner [38, 44]. We have reported that de-cant inhibition of cell migration and spreading of cells
phosphorylation of p130Cas and FAK by a phosphatase
incubated with either glucose or mannitol. Furthermore, results in suppression of cell spreading and migration
inhibition of cell spreading and migration by high glucose [24, 25]. Both p130Cas and FAK were phosphorylated
concentration could be reversed by intracellular over- after overexpression of FAK, but that p130Cas over-
expression of FAK, indicating that these alterations result expression resulted in only its own phosphorylation with-
from the specific inhibition of intracellular signaling in- out affecting the phosphorylation level of FAK [25].
volving FAK, not from non-specific effects of reduced These findings indicate that p130Cas is a downstream ef-
cell viability. Interestingly, acidic culture medium had fector in a signal transduction pathway leading to cell
minimal effects on both cell viability and migration. Ef- migration and is also implicated in glucose-induced inhi-
fects of extracellular acidosis on cell viability are poorly bition of mesothelial cell migration.
understood and controversial. Acidic pH has no effects In conclusion, our in vitro study showed that high
on neutrophil apoptosis [41], while acidosis induces ex- glucose concentrations suppressed wound healing of per-
pression of basic fibroblast growth factor (bFGF) and itoneal cell monolayer associated with inhibition of focal
vascular endothelial growth factor (VEGF), and inhibits adhesion formation and phosphorylation of FAK and
its downstream p130Cas. Mannitol also exhibited cell mi-endothelial cell apoptosis [42]. In the present study, we
gration inhibitory effects but they were less than thosecould not observe any significant effects of acidic culture
of glucose. Our results suggest that high glucose dialysatemedium on cell viability after 24-hours of exposure. Fur-
causes peritoneal damage by inhibiting wound repair ofther studies are needed to investigate the effects of acido-
the mesothelial monolayer, and that hypertonic dialy-sis on mesothelial cell viability.
sates should be used as less as possible for preservingOur results also showed that high glucose concentra-
the ability of mesothelial cells to regenerate woundedtions inhibited FN-induced FAK phosphorylation. FAK
mesothelial cell monolayer of the peritoneum.is thought to be a key molecule implicated in integrin
signaling pathways. Activation of integrins by cell bind-
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